SEC Form 4 · accession 0000899243-17-029313
Fuse Medical, Inc. · FZMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Christopher C Reeg
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Dec 14, 2017
Accepted (ET)
Dec 20, 2017 · 3:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000319016
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 14, 2017 | A | 188,500 | $0.20 | A | 4,253,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 14, 2017, the Reporting Person was granted 188,500 shares of the Issuer's restricted common stock, par value $0.01, pursuant to the 2017 Equity Incentive Plan of Fuse Medical, Inc. (incorporated by reference to Exhibit 99.2 to the Issuer's Form 8-K filed on April 6, 2017 (File No. 000-10093)), which will vest and cease to be subject to forfeiture (i) on September 21, 2018, or (ii) in accordance with the vesting provisions of the Restricted Stock Award Agreement (incorporated by reference to Exhibit 10.1 to the Issuer's Form 8-K filed on October 10, 2017 (File No. 000-10093)).